PL327997A1 - Methods of obtaining 1-(2-[-isoxazol-3-yl benzofuran-5-yloxy]ethylamine-3-phenoxy 2-(s)-ole and intermediate compounds - Google Patents

Methods of obtaining 1-(2-[-isoxazol-3-yl benzofuran-5-yloxy]ethylamine-3-phenoxy 2-(s)-ole and intermediate compounds

Info

Publication number
PL327997A1
PL327997A1 PL96327997A PL32799796A PL327997A1 PL 327997 A1 PL327997 A1 PL 327997A1 PL 96327997 A PL96327997 A PL 96327997A PL 32799796 A PL32799796 A PL 32799796A PL 327997 A1 PL327997 A1 PL 327997A1
Authority
PL
Poland
Prior art keywords
isoxazol
ole
benzofuran
yloxy
ethylamine
Prior art date
Application number
PL96327997A
Inventor
Keith M Devries
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL327997A1 publication Critical patent/PL327997A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL96327997A 1995-10-31 1996-08-15 Methods of obtaining 1-(2-[-isoxazol-3-yl benzofuran-5-yloxy]ethylamine-3-phenoxy 2-(s)-ole and intermediate compounds PL327997A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US815395P 1995-10-31 1995-10-31
PCT/IB1996/000803 WO1997016432A1 (en) 1995-10-31 1996-08-15 Processes and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(s)-ol

Publications (1)

Publication Number Publication Date
PL327997A1 true PL327997A1 (en) 1999-01-04

Family

ID=21730067

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96327997A PL327997A1 (en) 1995-10-31 1996-08-15 Methods of obtaining 1-(2-[-isoxazol-3-yl benzofuran-5-yloxy]ethylamine-3-phenoxy 2-(s)-ole and intermediate compounds

Country Status (15)

Country Link
EP (1) EP0861240A1 (en)
JP (1) JPH10513480A (en)
KR (1) KR19990067172A (en)
CN (1) CN1201455A (en)
AU (1) AU6628596A (en)
BR (1) BR9611217A (en)
CA (1) CA2234081A1 (en)
CZ (1) CZ130898A3 (en)
HR (1) HRP960502A2 (en)
HU (1) HUP9900090A3 (en)
IL (1) IL123623A0 (en)
PL (1) PL327997A1 (en)
TR (1) TR199800710T2 (en)
WO (1) WO1997016432A1 (en)
YU (1) YU57396A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120253481A1 (en) * 2011-03-29 2012-10-04 General Electric Company Hart channel interface component including redundancy
EP2653464B1 (en) * 2012-04-20 2017-09-27 Rohm and Haas Company Benzylamine hydrophobe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL312005A1 (en) * 1993-06-14 1996-04-01 Pfizer Binary amines as antidiabetic and antiobesitic agents

Also Published As

Publication number Publication date
WO1997016432A1 (en) 1997-05-09
CZ130898A3 (en) 1999-03-17
JPH10513480A (en) 1998-12-22
KR19990067172A (en) 1999-08-16
TR199800710T2 (en) 1998-08-21
IL123623A0 (en) 1998-10-30
EP0861240A1 (en) 1998-09-02
AU6628596A (en) 1997-05-22
HUP9900090A2 (en) 1999-10-28
CA2234081A1 (en) 1997-05-09
HRP960502A2 (en) 1998-04-30
MX9803497A (en) 1998-09-30
BR9611217A (en) 1999-04-06
CN1201455A (en) 1998-12-09
HUP9900090A3 (en) 1999-11-29
YU57396A (en) 1998-11-05

Similar Documents

Publication Publication Date Title
ZA975675B (en) Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one
IL117177A0 (en) Benzopyran-containing compounds and method for their use
SG55098A1 (en) Naphthyl compounds intermediates compounds and methods
GB9526560D0 (en) Use of 2-Amino-Heterocycles
PL318279A1 (en) Substituted derivatives of camptotecin and method of obtaining them
PL332482A1 (en) Intermediate compounds for and method of obtaining olanzaoine
PL323236A1 (en) Method of obtaining lerkanipidin chlorchydride
EG21286A (en) Blends of organosillane compounds and their use
PL324497A1 (en) Method of obtaining n-substituted 3-hydroxyparasoles
PL326973A1 (en) Method of obtaining 2-chlorothiazole compounds
ZA96725B (en) Use of phenyclyclohexylcarboxamides
PL337716A1 (en) Method of obtaining thiazafurin and other c-nucleosides
PL320699A1 (en) Method of obtaining cephotaxime
PL327147A1 (en) Method of obtaining dihydropyrimidinones
PL322908A1 (en) Method of obtaining racemic and enatiomeric 1-(pyridyl)-2-cyclohexyloethylamine
AU1081897A (en) Heterocyclic compounds and their use
PL325632A1 (en) Derivatives of pyrizin-2-one, their application and intermediate compounds for obtaining them
PL320320A1 (en) Method of and intermediate compounds for obtaining fluorolefine compounds exhibiting pesticidal properties
ZA969429B (en) Amidinohydrazones of ketones
PL327997A1 (en) Methods of obtaining 1-(2-[-isoxazol-3-yl benzofuran-5-yloxy]ethylamine-3-phenoxy 2-(s)-ole and intermediate compounds
PL326978A1 (en) Method of obtaining dioxyaza bicyclohexanes
PL321925A1 (en) Method of obtaining 1-(p-methoxybenzooyl)-2-pyrolydone
IL117813A0 (en) Use of heterocyclic compounds
PL312826A1 (en) Method of obtaining dilthiazeme
PL323605A1 (en) Method of obtaining substituted 5-hydroxy-oxazolydin-4-ones